Clinical Trials Browser

Phase 2 × Breast Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT02297698 2023-12-12

HER3+

Phase 2 Completed

100 enrolled 11 charts

Breast Neoplasms

NCT05603013 2022-11-02

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

Phase 2 Unknown

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00524277 2020-03-30

Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00343109 2020-02-12

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00254592 2019-02-28

Neoadjuvant Treatment of Breast Cancer

Phase 2 Completed

43 enrolled 7 charts

Breast Neoplasms

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Phase 2 Completed

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00429104 2012-12-06

Herceptin and GM-CSF for Metastatic Breast Cancer

Phase 2 Completed

18 enrolled 4 charts

Breast Neoplasms